Publications

PUBLICATIONS SUR LES TECHNOLOGIES DE REPLICOR CONCERNANT LES POLYMÈRES AMPHIPATHIQUES À BASE D’ADN (Publications en anglais seulement):

Amphipathic DNA polymers exhibit antiviral activity against systemic murine Cytomegalovirus infection. Cardin RD, Bravo FJ, Sewell AP, Cummins J, Flamand L, Juteau JM, Bernstein DI, Vaillant A.   Virology Journal 2009, 6:214.

http://www.virologyj.com/content/6/1/214

Amphipathic DNA polymers inhibit hepatitis C virus infection by blocking viral entry. Matsumura T, Hu Z, Kato T, Dreux M, Zhang YY, Imamura M, Hiraga N, Juteau JM, Cosset FL, Chayama K, Vaillant A, Liang TJ.  Gastroenterology. 2009 Aug;137(2):673-81.

http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WFX-4W4JDMM-3&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=3ab96606aeaf8699a6dc55f8e0c6cd48

Amphipathic DNA polymers exhibit antiherpetic activity in vitro and in vivo.  Bernstein DI, Goyette N, Cardin R, Kern ER, Boivin G, Ireland J, Juteau JM, Vaillant A.  Antimicrob Agents Chemother. 2008 Aug;52(8):2727-33

http://aac.asm.org/cgi/content/full/52/8/2727?view=long&pmid=18505857

Amphipathic DNA polymers are candidate vaginal microbicides and block herpes simplex virus binding, entry and viral gene expression.  Guzman EM, Cheshenko N, Shende V, Keller MJ, Goyette N, Juteau JM, Boivin G, Vaillant A, Herold BC.  Antivir Ther. 2007;12(8):1147-56. Erratum in: Antivir Ther. 2008;13(2):335.

http://www.intmedpress.com/serveFile.cfm?sUID=c68bdf9c-f6da-453e-a23b-977206156829

Inhibition of cellular entry of lymphocytic choriomeningitis virus by amphipathic DNA polymers.  Lee AM, Rojek JM, Gundersen A, Ströher U, Juteau JM, Vaillant A, Kunz S.  Virology. 2008 Mar 1;372(1):107-17

http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WXR-4R70JXH-4&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=a10d22859cf94cccdfc0da5b3b9ce1d2

Phosphorothioate oligonucleotides inhibit human immunodeficiency virus type 1 fusion by blocking gp41 core formation.  Vaillant A, Juteau JM, Lu H, Liu S, Lackman-Smith C, Ptak R, Jiang S.  Antimicrob Agents Chemother. 2006 Apr;50(4):1393-401.

http://aac.asm.org/cgi/content/full/50/4/1393?view=long&pmid=16569857